Connect Biopharma Holdings (CNTB) Non Operating Income (2024 - 2026)

Connect Biopharma Holdings (CNTB) has reported Non Operating Income for 3 consecutive years, with $257000.0 the latest figure, recorded in Q1 2026.

• Quarterly Non Operating Income fell 79.09% year-over-year to $257000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 57.76% YoY) and the FY2025 annual result came in at $2.8 million, down 60.39% from the prior year.
• Non Operating Income declined to $257000.0 in Q1 2026 per CNTB's latest filing, from $444000.0 in the prior quarter.
• Over the last five years, Non Operating Income for CNTB reached as high as $4.0 million in Q1 2024 and fell as low as $257000.0 in Q1 2026.
• A 3-year average of $1.1 million and a median of $819000.0 in 2024 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2025 — Non Operating Income plunged 45.79% — and 2026, when it slumped 79.09%.
• Year by year, Non Operating Income stood at $819000.0 in 2024, then tumbled by 45.79% to $444000.0 in 2025, then plunged by 42.12% to $257000.0 in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $257000.0, $444000.0, and $538000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.